Fox Run Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,111
Closed -$160K 922
2025
Q1
$160K Buy
+11,111
New +$160K 0.02% 823